Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s126. https://doi.org/10.25251/skin.1.supp.125